S.Africa's Aspen offers to buy GSK thrombosis drugs

LONDON, June 18 Tue Jun 18, 2013 7:13am EDT

LONDON, June 18 (Reuters) - GlaxoSmithKline said on Tuesday that South Africa's Aspen Pharmacare had offered to acquire its thrombosis drug brands Arixtra and Fraxiparine, along with the related manufacturing site.

Britain's biggest drugmaker said the proposed disposal fitted with its strategy of focusing on products with the most growth potential and the delivery of its pipeline.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.